Jorie Versmissen Selected Research

Jorie Versmissen Research Topics

Disease

22	Hypertension (High Blood Pressure) 01/2024 - 01/2015
10	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2018 - 04/2009
7	Neoplasms (Cancer) 10/2023 - 01/2019
7	Coronary Disease (Coronary Heart Disease) 01/2020 - 11/2008
6	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2019
4	Venous Thromboembolism 12/2023 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 01/2015
4	COVID-19 01/2021 - 01/2020
3	Albuminuria 11/2023 - 01/2020
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2019
3	Proteinuria 01/2023 - 01/2019
3	Atherosclerosis 05/2018 - 04/2010
3	Xanthomatosis (Xanthoma) 04/2010 - 09/2009
2	Thrombophilia 12/2023 - 01/2020
2	Thrombosis (Thrombus) 10/2023 - 07/2018
2	Stroke (Strokes) 11/2021 - 01/2015
2	Renal Insufficiency (Renal Failure) 01/2021 - 08/2015
2	Myocardial Infarction 01/2021 - 11/2008
2	Philadelphia Chromosome 12/2016 - 06/2016
2	Leukemia 12/2016 - 06/2016
1	Breast Neoplasms (Breast Cancer) 12/2023
1	Drug-Related Side Effects and Adverse Reactions 11/2022
1	Vascular Diseases (Vascular Disease) 11/2021
1	Disease Progression 01/2021
1	Orthostatic Hypotension (Postural Hypotension) 01/2021
1	Pulmonary Arterial Hypertension 03/2020
1	Hemorrhage 01/2020
1	Acute Coronary Syndrome 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Pulmonary Embolism 07/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2016

Drug/Important Bio-Agent (IBA)

11	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 01/2015
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 11/2008
6	CholesterolIBA 05/2018 - 04/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2019
5	Endothelins (Endothelin)IBA 01/2022 - 01/2019
4	LDL Receptors (LDL Receptor)IBA 03/2015 - 12/2011
3	Angiogenesis InhibitorsIBA 11/2023 - 01/2020
3	DiureticsIBA 01/2023 - 01/2015
3	SaltsIBA 01/2023 - 01/2015
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2019
3	macitentanIBA 03/2020 - 01/2020
3	fibrin fragment D (D-dimer)IBA 01/2019 - 07/2018
2	Sunitinib (Sutent)FDA Link 11/2023 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2021
2	ProstaglandinsIBA 01/2022 - 08/2020
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022 - 01/2019
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2020
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2020
2	Endothelin Receptor AntagonistsIBA 03/2020 - 01/2019
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2010 - 04/2009
2	LDL CholesterolIBA 12/2009 - 04/2009
1	Tamoxifen FDA LinkGeneric 12/2023
1	4-hydroxy-N-desmethyltamoxifenIBA 12/2023
1	Celecoxib (Celebrex)FDA Link 11/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2023
1	AnticoagulantsIBA 10/2023
1	Dietary SodiumIBA 01/2023
1	SodiumIBA 01/2023
1	4- (benzyloxy)- 2,6- diamino- 5- nitropyrimidineIBA 01/2023
1	Endothelin-1 (Endothelin 1)IBA 01/2023
1	ReninIBA 01/2023
1	Methyldopa (Aldomet)FDA LinkGeneric 11/2022
1	Labetalol (Normodyne)FDA LinkGeneric 11/2022
1	Nifedipine (Adalat)FDA LinkGeneric 11/2022
1	CanrenoneIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Superoxides (Superoxide)IBA 01/2022
1	Perindopril FDA LinkGeneric 11/2021
1	perindopril drug combination indapamideIBA 11/2021
1	Gliclazide (Diamicron)IBA 11/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Dopamine beta-HydroxylaseIBA 01/2021
1	ambrisentan FDA Link 03/2020
1	AngiotensinsIBA 01/2020
1	TicagrelorIBA 01/2020
1	Prasugrel Hydrochloride FDA Link 01/2020
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2020
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2019
1	PCSK9 InhibitorsIBA 12/2018
1	Fibrinogen (Factor I)FDA Link 12/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2016
1	Imatinib Mesylate (Gleevec)FDA Link 12/2016
1	HDL CholesterolIBA 07/2016
1	LipidsIBA 11/2015
1	C-Reactive ProteinIBA 11/2015
1	Dalteparin (Dalteparin Sodium)FDA Link 08/2015
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2015
1	Tinzaparin (Innohep)FDA Link 08/2015
1	Atorvastatin (Lipitor)FDA Link 01/2015

Therapy/Procedure

10	Therapeutics 10/2023 - 12/2011
1	Deprescriptions 11/2022
1	Critical Care (Surgical Intensive Care) 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Percutaneous Coronary Intervention 01/2020
1	Hematopoietic Stem Cell Transplantation 06/2016
1	Drug Tapering 08/2015
1	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2015